Switzerland Now Recognises Covaxin as Valid Proof of Immunity for Travel

Shortly after the World Health Organization (WHO) revealed that Covaxin had been given the green light and is now part of its emergency uses list, Swiss authorities revealed that the vaccine would be recognized as valid evidence of travel immunity.

Accordingly, this means that all who have completed vaccination with Covaxin are now eligible to enter Switzerland without having to undergo testing or quarantine requirements, TheSchengen.com reports.

“People who have been vaccinated with two different vaccines are considered to have been fully vaccinated if the vaccines used have been approved by the authorities in Switzerland and the European Union (EMA) or are on the World Health Organization’s List for Emergency Use and if given in accordance with the regulations or recommendations of the country in which they were given. vaccination,” reads the statement of the Swiss Federal Office of Public Health (FOPH).

The vaccination document indicating that the holder has been fully immunized against the virus with Covaxin or any other vaccine acceptable in Switzerland must be documented in the form of a recognized certificate and includes the following information about the holder:

Name and surname Date of birth Name of the vaccine given Date(s) when the dose(s) were given Issuer

>> Traveling to Switzerland in the midst of the COVID-19 pandemic: a complete guide

According to a press release from the World Health Organization, Covaxin was evaluated under a procedure based on a review of data regarding efficacy, quality, safety, risk management plan, and programmatic suitability. The two-dose vaccine is recommended for all age groups 18 and over and is exceptionally suitable for low- and middle-income countries due to simple storage requirements.

“This emergency use list expands the availability of vaccines, which are the most effective medical tools we have to end the pandemic,” said Dr Mariangela Simao, WHO Assistant Director-General for Access to Medicines and Health Products, commenting on Covaxin’s approval.

With the exception of newly recognized vaccines, Switzerland already recognizes all other certificates proving that the holder has been fully immunized with one of the other seven accepted vaccines – Pfizer / BioNTech (Comirnaty), Moderna (Spikevax), AstraZeneca (Vaxzevria), Johnson & Johnson (Janssen), Kovishield (Institute of Serum of India), Sinopharma (BIBP), Sinovac (CoronaVac).

Earlier, Switzerland announced that the country will no longer recognize certificates of vaccination against the emerging coronavirus, COVID-19, issued by third countries. Therefore, travelers arriving in Switzerland from countries outside the EU/Schengen area need to apply for a Swiss COVID-19 Card.

In order to avoid any inconvenience before travelling, it is highly recommended that all those planning to travel to Switzerland or any other country amid COVID-19 check the validity of their vaccine. This can be done by using the VisaGuide.World Vaccine Check Tool, which allows travelers around the world to check if their vaccine is acceptable by the destination country.

Schengen Visa

Schengen Countries

Schengen Agreement

Schengen News

Source: schengenvisainfo.com

Enable Notifications    OK No